Bilimsel çalışmalar

Doç. Dr. İlkay Gültürk

52 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Bone Pain Is Associated with Short Radiographic Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15103968 PMID 42194929 Açık erişimli tam metinKaynak: OpenAlex

  2. Association between obesity and outcomes of first-line CDK4/6 inhibitor therapy in metastatic breast cancer: a multicenter real-world study

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-58205-7 PMID 42304044 Açık erişimli tam metinKaynak: OpenAlex

  3. Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

    Cancers, 2026

    DOI 10.3390/cancers18142302 PMID 42512369 Açık erişimli tam metinKaynak: ORCID

  4. Kaposi Sarcoma Presenting as Hemophagocytic Lymphohistiocytosis Mimicking Infection and Lymphoma: A Diagnostic Challenge

    Cureus, 2026

    DOI 10.7759/cureus.105780 PMID 42037832 Açık erişimli tam metinKaynak: OpenAlex

  5. The Clinical Significance of Gallium‐68 PSMA‐11 PET‐Derived SUVmax in the Management of Metastatic Hormone‐Sensitive Prostate Cancer

    The Prostate, 2026

    DOI 10.1002/pros.70185 PMID 42018584 Açık erişimli tam metinKaynak: ORCID

  6. Bone Pain Is Associated with Short Radiologic-Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer

    2026

    DOI 10.20944/preprints202604.1309.v1 Açık erişimli tam metinKaynak: ORCID

  7. Association of Pretreatment IronMLR and ANR With Pathological Response Following Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

    SSRN Electronic Journal, 2026

    DOI 10.2139/ssrn.7100220 Açık erişimli tam metinKaynak: ORCID

  8. Association of Pretreatment ANR and IronMLR With Pathological Response Following Neoadjuvant Chemotherapy in Breast Cancer

    Breast Cancer Targets and Therapy, 2026

    DOI 10.2147/bctt.s623894 PMID 42677318 Açık erişimli tam metinKaynak: OpenAlex

  9. A multi-center case-control study on osteoporosis risk in cancer patients receiving chemotherapy.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.12033 Kaynak: OpenAlex

  10. A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-09973-x PMID 41225034 1 atıf (Europe PMC) Kaynak: OpenAlex

  11. Very deep prostate-specific antigen decline is associated with longer rPFS in patients with metastatic castration-sensitive prostate cancer

    Therapeutic Advances in Medical Oncology, 2025

    DOI 10.1177/17588359251369037 PMID 40895017 Açık erişimli tam metinKaynak: OpenAlex

  12. Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-96157-6 PMID 40188172 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  13. The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors

    Cancers, 2025

    DOI 10.3390/cancers17040693 PMID 40002286 14 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  14. Evaluation of Dose Reduction Factors and Impact on Progression-Free Survival in Patients Treated with CDK 4/6 Inhibitors

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14041071 PMID 40004601 9 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  15. Prognostic Importance of PTEN and P53 in Aggressive Luminal A Subtype Breast Cancers

    European journal of breast health, 2025

    DOI 10.4274/ejbh.galenos.2025.2025-2-12 PMID 40390381 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

  16. The Relationship Between Changes in the Neutrophil-Lymphocyte Ratio (NLR) and Radiological Progression in Cervical Cancer

    Istanbul Medical Journal, 2025

    DOI 10.4274/imj.galenos.2025.59254 Açık erişimli tam metinKaynak: OpenAlex

  17. 18F-FDG PET/CT Findings Mimicking Gallbladder Metastasis From a Rectal Adenocarcinoma: Rare Synchronous Gallbladder and Rectal Cancer

    Clinical Nuclear Medicine, 2025

    DOI 10.1097/rlu.0000000000005812 PMID 40029796 Kaynak: OpenAlex

  18. The impact of sarcopenia on adverse effects and survival in patients with metastatic hormone receptor-positive breast cancer treated with CDK4/6 inhibitors

    Medicine, 2025

    DOI 10.1097/md.0000000000043374 PMID 40660511 Açık erişimli tam metinKaynak: ORCID

  19. The Prognostic Value of the EASIX Score in Patients with Metastatic Pancreatic Cancer

    Diagnostics, 2025

    DOI 10.3390/diagnostics15141740 PMID 40722492 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  20. 68Ga PSMA PET/CT and 18F FDG PET/CT Findings in Osteonecrosis of the Jaw Induced by Denosumab

    Clinical Nuclear Medicine, 2025

    DOI 10.1097/rlu.0000000000005751 PMID 40025661 5 atıf (OpenAlex) Kaynak: OpenAlex

  21. The relationship between body mass index and survival in patients with renal cell carcinoma treated with nivolumab

    Journal of Chemotherapy, 2025

    DOI 10.1080/1120009x.2025.2469371 PMID 39988757 2 atıf (OpenAlex) Kaynak: OpenAlex

  22. The Role of Magnetic Resonance Imaging in Predicting Pathological Complete Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

    Bagcilar Medical Bulletin, 2025

    DOI 10.4274/bmb.galenos.2025.33042 Açık erişimli tam metinKaynak: OpenAlex

  23. Evaluación de la eficacia del tratamiento según los criterios RECIP 1.0 en el cáncer de próstata sensible a la castración

    Actas Urológicas Españolas, 2025

    DOI 10.1016/j.acuro.2025.501837 Kaynak: OpenAlex

  24. Evaluation of treatment efficacy according to RECIP 1.0 criteria in castration-sensitive prostate cancer

    Actas Urológicas Españolas (English Edition), 2025

    DOI 10.1016/j.acuroe.2025.501837 PMID 40939837 Kaynak: OpenAlex

  25. 2407P Elevated SUVmax on gallium-68-PSMA-11 PET (PSMA-PET) is associated with shorter radiographic progression-free survival (rPFS) in patients with metastatic castration-sensitive prostate cancer (mCSPC)

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3023 Açık erişimli tam metinKaynak: OpenAlex

  26. Relationship of Neoadjuvant Chemotherapy Efficacy with Histopathologic Molecular Subtypes in Breast Cancer Patients

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.96266 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  27. Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function

    Actas Urológicas Españolas (English Edition), 2024

    DOI 10.1016/j.acuroe.2024.04.002 PMID 38570033 Kaynak: OpenAlex

  28. The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study

    Breast Cancer Research and Treatment, 2024

    DOI 10.1007/s10549-024-07291-0 PMID 38526689 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  29. Could macrocytosis predict survival In advanced breast cancer patients that were treated with CDK 4–6 inhibitors?

    The Breast, 2024

    DOI 10.1016/j.breast.2024.103820 PMID 39405594 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  30. Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes

    Cancers, 2024

    DOI 10.3390/cancers16223880 PMID 39594835 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  31. The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-75293-5 PMID 39384975 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  32. Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer

    Journal of College of Physicians And Surgeons Pakistan, 2024

    DOI 10.29271/jcpsp.2024.01.37 PMID 38185958 5 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  33. Assessment of Oral Capecitabine in Elderly Patients with Stage 2 Colon Cancer: Toxicity, Tolerability, and Survival Outcomes

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.64606 Açık erişimli tam metinKaynak: OpenAlex

  34. Comparison of Coronary Artery Calcium Score and Serum Calcium, Phosphorus, and Gamma-Glutamyl Transferase Levels in Patients with Coronary Artery Imaging by Multi-Sectional Computed Tomography with Chronic Ischemic Heart Disease Prediagnosis

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.14602 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  35. Nivolumab treatment in a patient with BRAF mutant advanced melanoma and liver failure with encephalopathy

    Journal of Oncology Pharmacy Practice, 2024

    DOI 10.1177/10781552231221230 PMID 38111303 Kaynak: ORCID

  36. Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes

    2024

    DOI 10.20944/preprints202410.2285.v1 Açık erişimli tam metinKaynak: ORCID

  37. Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer

    Asia-Pacific Journal of Clinical Oncology, 2024

    DOI 10.1111/ajco.14065 PMID 38572819 2 atıf (OpenAlex) Kaynak: OpenAlex

  38. Seguridad y eficacia del nivolumab para el tratamiento de pacientes con carcinoma de células renales metastásico e insuficiencia renal

    Actas Urológicas Españolas, 2024

    DOI 10.1016/j.acuro.2024.01.014 Kaynak: OpenAlex

  39. Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?

    Supportive Care in Cancer, 2023

    DOI 10.1007/s00520-023-07791-7 PMID 37162602 4 atıf (Europe PMC) Kaynak: ORCID

  40. Naples prognostic score may predict overall survival in metastatic pancreatic cancer

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_1392_22 PMID 38554329 12 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  41. Naples Score May Predict Overall Survival in Metastatic Gastric Cancer and is Superior to CONUT

    Acta Oncologica Turcica, 2023

    DOI 10.5505/aot.2023.80269 Açık erişimli tam metinKaynak: OpenAlex

  42. Partial Atrophy of The Pancreas in Endoscopic Ultrasonography may be a Sign of Pancreatic Cancer

    Istanbul Medical Journal, 2023

    DOI 10.4274/imj.galenos.2023.52386 Açık erişimli tam metinKaynak: ORCID

  43. Temel Onkoloji

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1765 Kaynak: OpenAlex

  44. Nivolumab induced hypophysitis in an advanced RCC patient

    Journal of Oncology Pharmacy Practice, 2022

    DOI 10.1177/10781552211072212 PMID 35006033 3 atıf (OpenAlex) Kaynak: OpenAlex

  45. With metastatic colorectal cancer: A single center experience use of monoclonal antibodies (Bevacizumab, Cetuximab, and Panitumumab) in patients

    Journal of Experimental and Clinical Medicine, 2022

    DOI 10.52142/omujecm.39.4.34 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  46. Lutetium-Associated Myopathy: A Case Report

    American Journal of Therapeutics, 2022

    DOI 10.1097/mjt.0000000000001491 PMID 35383588 1 atıf (OpenAlex) Kaynak: OpenAlex

  47. Time to Castration Resistance as a Predictor of Response to Docetaxel in Metastatic Castration Resistance in Prostate Cancer

    Istanbul Medical Journal, 2022

    DOI 10.4274/imj.galenos.2022.56804 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  48. Prosnostic Significance of Prognostic Nutrition Index in Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors

    Namık Kemal Tıp Dergisi, 2022

    DOI 10.4274/nkmj.galenos.2022.80764 Açık erişimli tam metinKaynak: OpenAlex

  49. Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders

    The Turkish Journal of Gastroenterology, 2022

    DOI 10.5152/tjg.2022.20844 PMID 35678799 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  50. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study

    Melanoma Research, 2021

    DOI 10.1097/cmr.0000000000000744 PMID 34039945 16 atıf (Europe PMC) Kaynak: OpenAlex